activity
20182024
most citedDiversity Policy Gradient for Sample Efficient Quality-Diversity Optimization

40 citations · 148 across the 12 of their papers we have counts for

collaborators

12 papers

q-bio.QM2024

Protein binding affinity prediction under multiple substitutions applying eGNNs on Residue and Atomic graphs combined with Language model information: eGRAL

Arturo Fiorellini-Bernardis, Sebastien Boyer, Christoph Brunken +4

Protein-protein interactions (PPIs) play a crucial role in numerous biological processes. Developing methods that predict binding affinity changes under substitution mutations is f…

cs.NE2022★ 2 cited

Assessing Quality-Diversity Neuro-Evolution Algorithms Performance in Hard Exploration Problems

Felix Chalumeau, Thomas Pierrot, Valentin Macé +4

A fascinating aspect of nature lies in its ability to produce a collection of organisms that are all high-performing in their niche. Quality-Diversity (QD) methods are evolutionary…

cs.LG2022★ 1 cited

Fast Population-Based Reinforcement Learning on a Single Machine

Arthur Flajolet, Claire Bizon Monroc, Karim Beguir +1

Training populations of agents has demonstrated great promise in Reinforcement Learning for stabilizing training, improving exploration and asymptotic performance, and generating a…

cs.AI2022★ 32 cited

Multi-Objective Quality Diversity Optimization

Thomas Pierrot, Guillaume Richard, Karim Beguir +1

In this work, we consider the problem of Quality-Diversity (QD) optimization with multiple objectives. QD algorithms have been proposed to search for a large collection of both div…

cs.LG2021★ 2 cited

Mava: a research library for distributed multi-agent reinforcement learning in JAX

Ruan de Kock, Omayma Mahjoub, Sasha Abramowitz +5

Multi-agent reinforcement learning (MARL) research is inherently computationally expensive and it is often difficult to obtain a sufficient number of experiment samples to test hyp…

q-bio.BM2020★ 2 cited

Designing a Prospective COVID-19 Therapeutic with Reinforcement Learning

Marcin J. Skwark, Nicolás López Carranza, Thomas Pierrot +6

The SARS-CoV-2 pandemic has created a global race for a cure. One approach focuses on designing a novel variant of the human angiotensin-converting enzyme 2 (ACE2) that binds more…